Equity Brief · Healthcare2026-05-20
MDT·Healthcare

Medtronic PLC

I · KI-Analyse

Kurzfassung

Medtronic manufactures and sells medical devices across four main areas: heart devices like pacemakers and heart valves, neuroscience products including spinal implants and brain stimulation systems, surgical tools including robotic-assisted surgery platforms, and diabetes management products like insulin pumps and glucose monitors [Company Overview]. The company serves hospitals, physicians, and patients in over 150 countries worldwide.

Medtronic is a major medical device company that makes cardiac devices, spinal implants, surgical tools, and diabetes management systems. The company faces moderate financial health concerns with slowing growth and operational inefficiencies [Yahoo Finance], but it maintains a 48-year dividend growth streak and is investing in AI-powered surgical robotics [Yahoo Finance]. Recent news highlights leadership changes in key divisions and positive momentum in new therapy development [Simply Wall St, Yahoo Finance].

Medtronic shows moderate financial concerns with slow growth and modest returns despite strong cash flow generation.

Kurzfassung AI analysisKonfidenz 7/10

Sentinellis-Score

5.3/10

Moderate concerns

Marktkapitalisierung

$100.9B

Umsatz (12 Monate)

$33.5B

II · Aktuelle Nachrichten

Was den Kurs bewegt hat

6 stories · ranked by relevance

  • macro2026-05-18

    Mental Health Matters at Medtronic. Explore Our Employee Benefits

    Yahoo Finance

  • macro2026-05-19

    Medtronic Neuroscience Appointment Puts Focus On Execution And Growth Risks

    Simply Wall St

  • macro2026-05-18

    Medtronic (MDT) Advances While Market Declines: Some Information for Investors

    Yahoo Finance

  • macro2026-05-18

    Middle East and Africa Wearable Injectors Market Trends and Forecast Report 2026-2035 Featuring Amgen, BD, Biocon, Gerresheimer, Insulet, J&J, Medtronic, Roche, West Pharmaceutical, Ypsomed

    Yahoo Finance

  • macro2026-05-17

    A Once-in-a-Decade Opportunity: 1 Stock to Buy Hand Over Fist and Hold for Years

    Yahoo Finance

  • macro2026-05-14

    Should Medtronic’s AVIM Hypertension Trial Shift Require Action From Medtronic (MDT) Investors?

    Yahoo Finance

Premium · kostenlos mit jedem Konto

Revenue growth of only 3.6% year-over-year is significantly slower than historical medtech sector averages, suggesting Medtronic may be losing competitive ground [Yahoo Finance]

1 von 5 Risiken in diesem Bericht

Risiken

5

Chancen

6

Warnsignale

3

Führung

10

23 weitere Erkenntnisse im vollständigen Bericht — kostenlos mit jedem Konto.

Vollständige Medtronic PLC-Analyse freischalten

Erstellen Sie ein kostenloses Konto für den vollständigen KI-Bericht mit Quellenangaben im Text.

  • 5 Risiken, 6 Chancen und 3 Warnsignale — jeweils mit Quelle
  • Über 100 Finanzkennzahlen mit Charts und Vergleichen
  • Vollständige Nachrichten-Zusammenfassungen mit Quellenlinks
  • Führungsteam und Vergütung
  • PDF-Export für offline
Alle 14 Erkenntnisse freischalten3 kostenlose Berichte · keine Karte

III · Ähnliche Unternehmen

Das könnte Sie auch interessieren

Same sector · Healthcare or comparable health

Auf Ihre Watchlist setzen?

Read three companies free. Keine Karte.

3 kostenlose Berichte sichern
Medtronic PLC (MDT) Aktienanalyse in verständlicher Sprache — Sentinellis